Welcome to our dedicated page for Palomar Holdings SEC filings (Ticker: PLMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Palomar Holdings, Inc. filings document the regulatory record of a specialty property and casualty insurer with common stock listed on Nasdaq. Its 8-K reports disclose quarterly and annual results, including underwriting metrics, premium growth, loss ratios, combined ratios, non-GAAP measures and related earnings releases.
Palomar’s SEC filings also cover capital-structure and corporate matters, including share repurchase authorizations, credit facilities, material agreements and completed acquisition activity affecting its subsidiary base. Proxy materials document annual meeting proposals, board governance, executive compensation and stockholder voting matters, while Regulation FD filings provide investor presentation materials and risk-related disclosure language.
A holder of common stock in symbol PLMR has filed a notice of proposed sales under Rule 144. The filing lists three planned NASDAQ transactions of 1,260, 428, and 2,566 shares, with aggregate market values of 157,437, 53,479, and 320,622, respectively. All trades are to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, with expected sale dates of January 29, 2026 and January 31, 2026.
The securities were acquired from the issuer as restricted stock and performance stock, treated as compensation. Acquisitions occurred on January 29, 2026 and January 31, 2026, with corresponding payment dates the same days. The signer represents they are not aware of undisclosed material adverse information about the issuer’s operations.
PLMR insider Jonathan Knutzen has filed a Rule 144 notice to sell common stock of the issuer. The filing lists three planned sales through Morgan Stanley Smith Barney on NASDAQ: 1,598 shares with an aggregate market value of $199,670 around 01/29/2026, and 534 shares valued at $66,723 plus 3,204 shares valued at $400,340 around 01/31/2026. The issuer reports 26,494,524 common shares outstanding.
The securities to be sold were acquired from the issuer as restricted stock and performance stock awards, treated as compensation on 01/29/2026 and 01/31/2026. The form also notes that Knutzen sold 281 common shares for gross proceeds of $36,204 on 11/18/2025. By signing, the seller represents they are not aware of any undisclosed material adverse information about the issuer.
An investor associated with PLMR filed a Rule 144 notice to sell up to 612 shares of common stock through Morgan Stanley Smith Barney LLC on or after 01/29/2026 on the NASDAQ. The filing lists an aggregate market value of 76469 for these shares and shows total common shares outstanding of 26,494,524. The securities to be sold were acquired as restricted stock compensation on 01/29/2026, with 1,020 common shares granted and paid as compensation. By signing, the seller represents that they are not aware of any undisclosed material adverse information about PLMR.
Palomar Holdings CEO and Chairman Mac Armstrong reported that the Armstrong Family Trust sold a total of 5,000 shares of Palomar common stock on January 21, 2026. The sales were executed in multiple trades at weighted average prices of $127.8419, $128.6661, $129.7523, and $130.2893 per share. After these transactions, the trust held 348,388 shares indirectly, while Armstrong also held 80,314 shares directly.
The directly held amount includes 2,652 shares acquired through Palomar’s 2019 Employee Stock Purchase Plan, indicating ongoing participation in the employee equity program even as the family trust trimmed its position.
A shareholder of PLMR has filed a Rule 144 notice to sell 5,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of 653,150.00. The shares are listed on NASDAQ, and shares outstanding were 26,501,692 at the time of the notice. The securities to be sold were acquired from the issuer as restricted stock units, including 3,940 shares acquired on 01/15/2026 and 1,060 shares acquired on 01/26/2023. Over the past three months, related sales included 2,310 common shares sold by Marc Armstrong on 01/15/2026 for gross proceeds of 300,300.00, and 5,000-share 10b5-1 sales by the Armstrong Family Trust on each of 12/22/2025 and 11/21/2025, with proceeds of 681,139.00 and 614,311.00, respectively.
Palomar Holdings, Inc.'s CEO and Chairman Mac Armstrong reported exercising 6,250 Restricted Stock Units on January 15, 2026, receiving an equal number of common shares, and reporting a sale of 2,310 shares at $130.00 per share.
Following these transactions, he held 80,314 shares of Common Stock (RSUs) directly, 76,374 common shares directly and 353,388 common shares indirectly through the Armstrong Family Trust. A prior RSU grant covered 125,000 shares with time-based vesting described in the award agreement.
Palomar executive Mac Armstrong plans to sell 3,750 common shares under Rule 144, using Morgan Stanley Smith Barney as broker, with an aggregate market value of $487,350. The notice lists 26,494,524 common shares outstanding and targets an approximate sale date of January 15, 2026 on the NASDAQ exchange.
The shares to be sold were acquired as restricted stock compensation on January 15, 2026, in a grant of 6,250 shares fully paid as compensation. Recent activity also shows sales under a 10b5-1 trading plan, including three 5,000-share common stock sales on October 21, November 21, and December 22, 2025, plus a 3,218-share sale on October 15, 2025. By signing the notice, the seller represents they do not know of undisclosed material adverse information about Palomar’s current or prospective operations.
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 2,698,278 shares of Palomar Holdings Inc. common stock, representing 10.18% of the class as of 12/31/2025.
Vanguard reports no sole voting power, with 189,596 shares subject to shared voting power. It has sole dispositive power over 2,475,347 shares and shared dispositive power over 222,931 shares.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Palomar Holdings. Dividends and sale proceeds are attributable to Vanguard’s clients, and no single other person has an interest in more than 5% of the class.
Palomar Holdings, Inc. reported that one of its directors exercised stock options to acquire 1,278 shares of common stock on December 12, 2025 at an exercise price of $23.46 per share.
After this transaction, the director beneficially owned 8,051 shares of common stock and 2,984 stock options, all held directly. The exercised options relate to a grant where 50% of the shares vested on May 21, 2020 and the remaining shares vested in twelve equal successive monthly installments, and the option carries an expiration date of May 21, 2029.
Palomar Holdings, Inc. insider activity: The CEO and Chairman, reporting as a director and officer, disclosed stock sales on 11/21/2025. Through the Armstrong Family Trust, the reporting person sold a total of 5,000 shares of Palomar common stock in several open market transactions at weighted average prices of $120.3434, $121.8670, $123.0141, and $123.9782, across specified price ranges. After these transactions, the reporting person beneficially owns 76,374 shares directly and 358,388 shares indirectly via the Armstrong Family Trust. The direct holdings include 2,652 shares acquired under Palomar’s 2019 Employee Stock Purchase Plan.